Literature DB >> 11730072

Reaction-times and bioelectrical brain signals of drug-naive schizophrenic first-onset patients in identification and classification tasks.

S Krieger1, S Lis, B Gallhofer.   

Abstract

OBJECTIVE: The question of the present study is whether disturbances of response-selection in schizophrenic patients are discernible only if overt motor-actions are required, or also if covert cognitive actions are necessary.
METHOD: Visual identification (digits) and classification (dot-enumeration) tasks were presented to 18 drug-naive, first-onset schizophrenic patients and healthy controls. It is assumed that enumeration of more than three dots requires additional cognitive processes as buffering and re-focusing of attention. Reaction-times and 21-channel-EEG were measured. For eye-movement artefact-elimination a new non-parametric regression approach was applied.
RESULTS: Reaction-times revealed that in the patient group response selection is lengthened in both tasks. Perception of dot numbers is not affected. Bioelectrical data depicted a left-lateralization of posterior P100 and N 100 in the patient group as well as an enhanced fronto-central P200.
CONCLUSION: Whereas in reaction-times of patients only a disturbance of response selection is discernible, bioelectrical measurements also point to an altered organization of perceptive processes.

Entities:  

Mesh:

Year:  2001        PMID: 11730072     DOI: 10.1034/j.1600-0447.2001.104s408042.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  2 in total

1.  Sustained versus transient brain responses in schizophrenia: the role of intrinsic neural activity.

Authors:  Lauren Ethridge; Stephan Moratti; Yuan Gao; Andreas Keil; Brett A Clementz
Journal:  Schizophr Res       Date:  2011-08-11       Impact factor: 4.939

2.  Response selection impairment in schizophrenia transcends sensory and motor modalities.

Authors:  Neil D Woodward; Brittney Duffy; Haleh Karbasforoushan
Journal:  Schizophr Res       Date:  2013-12-19       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.